Johnson & Johnson Pauses Vaccine Trial After ‘Unexplained Illness’ Strikes Participant

Johnson & Johnson Pauses Vaccine Trial After ‘Unexplained Illness’ Strikes Participant


Johnson & Johnson announced Monday they are suspending their coronavirus vaccine trial after a participant came down with a mystery illness.

“There is no greater priority than the safety and well being of the people we serve every day around the world,” Johnson & Johnson said in a statement. “We have temporarily paused further dosing in all our COVID-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to an unexplained illness in a study participant.”

The company said illnesses are expected in large studies, and that they “can reasonably” expect more participants to show illness symptoms. The trial was paused after the patient’s condition was evaluated by the ENSEMBLE independent Data Safety Monitoring Board. It’s unclear what symptoms the participant showed.

Trending: President Trump Inspires New “Trump Dance Challenge” Online and People Are Loving It!

A staff member works during a media tour of a new factory built to produce a COVID-19 coronavirus vaccine at Sinovac, one of 11 Chinese companies approved to carry out clinical trials of potential coronavirus vaccines, in Beijing on September 24, 2020. (Photo by WANG ZHAO / AFP) (Photo by WANG ZHAO/AFP via Getty Images)

A staff member works during a media tour of a

Continue reading

You Might Like

Do NOT follow this link or you will be banned from the site!